Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Thousands | Total | Common Stock | Paid-in Capital | Retained Earnings |
Beginning balance (in shares) at Dec. 31, 2020 | | 12,366,593 | | |
Beginning Balance at Dec. 31, 2020 | $ 14,174 | $ 124 | $ (1,379) | $ 15,429 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | |
Net income (loss) | (3,064) | | | (3,064) |
Common stock issuance (in shares) | | 7,779 | | |
Common stock issuance | 21 | | 21 | |
Restricted stock issuance, net of forfeitures (in shares) | | (10,000) | | |
Restricted stock issuance, net of forfeitures | (1) | $ (1) | | |
Stock option exercise (in shares) | | 49,000 | | |
Stock option exercise | 89 | | 89 | |
Amortization of stock-based compensation | 246 | | 246 | |
Ending balance (in shares) at Mar. 31, 2021 | | 12,413,372 | | |
Ending Balance at Mar. 31, 2021 | 11,466 | $ 124 | (1,023) | 12,364 |
Beginning balance (in shares) at Dec. 31, 2020 | | 12,366,593 | | |
Beginning Balance at Dec. 31, 2020 | 14,174 | $ 124 | (1,379) | 15,429 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | |
Net income (loss) | (4,549) | | | |
Ending balance (in shares) at Sep. 30, 2021 | | 12,610,229 | | |
Ending Balance at Sep. 30, 2021 | 10,427 | $ 126 | (578) | 10,879 |
Beginning balance (in shares) at Mar. 31, 2021 | | 12,413,372 | | |
Beginning Balance at Mar. 31, 2021 | 11,466 | $ 124 | (1,023) | 12,364 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | |
Net income (loss) | (2,124) | | | (2,124) |
Restricted stock issuance (in shares) | | 98,000 | | |
Restricted stock issuance | 0 | $ 1 | (1) | |
Amortization of stock-based compensation | 279 | | 279 | |
Ending balance (in shares) at Jun. 30, 2021 | | 12,511,372 | | |
Ending Balance at Jun. 30, 2021 | 9,620 | $ 125 | (745) | 10,240 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | |
Net income (loss) | 639 | | | 639 |
Restricted stock issuance (in shares) | | 98,857 | | |
Restricted stock issuance | 0 | $ 1 | (1) | |
Stock option exercise | 0 | $ 1 | (1) | |
Amortization of stock-based compensation | 169 | | 169 | |
Ending balance (in shares) at Sep. 30, 2021 | | 12,610,229 | | |
Ending Balance at Sep. 30, 2021 | $ 10,427 | $ 126 | (578) | 10,879 |
Beginning balance (in shares) at Dec. 31, 2021 | 13,041,127 | 13,041,127 | | |
Beginning Balance at Dec. 31, 2021 | $ 9,315 | $ 130 | 335 | 8,850 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | |
Net income (loss) | (1,394) | | | (1,394) |
Common stock issuance (in shares) | | 143,985 | | |
Common stock issuance | 168 | $ 2 | 166 | |
Restricted stock issuance (in shares) | | 4,000 | | |
Restricted stock issuance | 0 | $ 0 | 0 | |
Amortization of stock-based compensation | 247 | | 247 | |
Ending balance (in shares) at Mar. 31, 2022 | | 13,189,112 | | |
Ending Balance at Mar. 31, 2022 | $ 8,336 | $ 132 | 748 | 7,456 |
Beginning balance (in shares) at Dec. 31, 2021 | 13,041,127 | 13,041,127 | | |
Beginning Balance at Dec. 31, 2021 | $ 9,315 | $ 130 | 335 | 8,850 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | |
Net income (loss) | $ 964 | | | |
Ending balance (in shares) at Sep. 30, 2022 | 14,043,642 | 14,043,642 | | |
Ending Balance at Sep. 30, 2022 | $ 12,470 | $ 140 | 2,516 | 9,814 |
Beginning balance (in shares) at Mar. 31, 2022 | | 13,189,112 | | |
Beginning Balance at Mar. 31, 2022 | 8,336 | $ 132 | 748 | 7,456 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | |
Net income (loss) | 875 | | | 875 |
Common stock issuance (in shares) | | 30,745 | | |
Common stock issuance | 38 | | 38 | |
Restricted stock forfeitures (in shares) | | (51,666) | | |
Restricted stock forfeitures | 0 | $ (1) | 1 | |
Amortization of stock-based compensation | 103 | | 103 | |
Ending balance (in shares) at Jun. 30, 2022 | | 13,168,191 | | |
Ending Balance at Jun. 30, 2022 | 9,353 | $ 132 | 890 | 8,331 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | |
Net income (loss) | 1,483 | | | 1,483 |
Common stock issuance (in shares) | | 717,451 | | |
Common stock issuance | 1,421 | $ 7 | 1,414 | |
Restricted stock issuance, net of forfeitures (in shares) | | 108,000 | | |
Restricted stock issuance, net of forfeitures | 0 | $ 1 | (1) | |
Stock option exercise (in shares) | | 50,000 | | |
Stock option exercise | 64 | $ 1 | 63 | |
Amortization of stock-based compensation | $ 150 | | 150 | |
Ending balance (in shares) at Sep. 30, 2022 | 14,043,642 | 14,043,642 | | |
Ending Balance at Sep. 30, 2022 | $ 12,470 | $ 140 | $ 2,516 | $ 9,814 |